CorMedix Inc. (CRMD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 200M 400M 600M Q4 '13: 2K Q1 '14: 14.2K Q2 '14: 53.9K Q3 '14: 106.4K Q4 '14: 189.3K Q1 '15: 208.3K Q2 '15: 288.6K Q3 '15: 272.1K Q4 '15: 187.2K Q1 '16: 197.4K Q2 '16: 93.9K Q3 '16: 102.4K Q4 '16: 102.5K Q1 '17: 100.6K Q2 '17: 220.3K Q3 '17: 236.9K Q4 '17: 329.3K Q1 '18: 313K Q2 '18: 184.4K Q3 '18: 495.8K Q4 '18: 429.8K Q1 '19: 570.3K Q2 '19: 598K Q3 '19: 285K Q4 '19: 283.3K Q1 '20: 193.6K Q2 '20: 174.8K Q3 '20: 208.3K Q4 '20: 239.2K Q1 '21: 253.4K Q2 '21: 245.2K Q3 '21: 190.3K Q4 '21: 190.9K Q1 '22: 110.3K Q2 '22: 123.4K Q3 '22: 92.1K Q4 '22: 65.4K Q1 '25: 82.6M Q2 '25: 121.5M Q3 '25: 214.3M Q4 '25: 311.7M Q1 '26: 400.1M Q2 '26: 462.2M Q4 '13 Q2 '15 Q4 '16 Q2 '18 Q4 '19 Q2 '21 Q4 '22 Q2 '26

Gross Profit TTM

-150M 0 150M 300M 450M Q4 '13: -199.6K Q1 '14: -268.4K Q2 '14: -283.2K Q3 '14: -267.4K Q4 '14: -256.5K Q1 '15: -173.8K Q2 '15: -140.8K Q3 '15: -156K Q4 '15: 32.5K Q1 '16: 9.8K Q2 '16: -179.1K Q3 '16: -179.1K Q4 '16: -178.9K Q1 '17: -224.1K Q2 '17: 64.7K Q3 '17: 58.6K Q4 '17: 214.4K Q1 '18: 263K Q2 '18: 118.8K Q3 '18: 184.4K Q4 '18: 33K Q1 '19: -24.9K Q2 '19: 15.4K Q3 '19: -64.2K Q4 '19: -90K Q1 '20: -1.2K Q2 '20: -18K Q3 '20: 14.6K Q4 '20: 34.4K Q1 '21: 35.8K Q2 '21: 32.3K Q3 '21: 32.1K Q4 '21: 42K Q1 '22: 21.2K Q2 '22: 48.3K Q3 '22: 40.8K Q4 '22: 61.7K Q4 '24: 40.3M Q1 '25: 78.6M Q2 '25: 116.2M Q3 '25: 198.5M Q4 '25: 275.7M Q1 '26: 343.4M Q2 '26: 382.6M Q1 '14 Q3 '15 Q1 '17 Q3 '18 Q1 '20 Q3 '21 Q4 '24 Q2 '26

Operating Income TTM

-80M 0 80M 160M 240M Q4 '10: -8.5M Q1 '11: -7.1M Q2 '11: -8.4M Q3 '11: -9.6M Q4 '11: -7.2M Q1 '12: -6.1M Q2 '12: -4.2M Q3 '12: -2.6M Q4 '12: -3M Q1 '13: -2.9M Q2 '13: -3.6M Q3 '13: -3.8M Q4 '13: -4.9M Q1 '14: -7M Q2 '14: -7.6M Q3 '14: -8.3M Q4 '14: -8.9M Q1 '15: -9.9M Q2 '15: -12.1M Q3 '15: -15M Q4 '15: -12.8M Q1 '16: -13M Q2 '16: -13.8M Q3 '16: -18.2M Q4 '16: -18.2M Q1 '17: -21.7M Q2 '17: -23.8M Q3 '17: -22.7M Q4 '17: -32.9M Q1 '18: -35.5M Q2 '18: -37M Q3 '18: -39.3M Q4 '18: -26.9M Q1 '19: -21.6M Q2 '19: -18.6M Q3 '19: -13.5M Q4 '19: -21M Q1 '20: -21.7M Q2 '20: -25.1M Q3 '20: -26.5M Q4 '20: -27.2M Q1 '21: -28.8M Q2 '21: -25.8M Q3 '21: -27.7M Q4 '21: -29.4M Q1 '22: -29.3M Q2 '22: -31.6M Q3 '22: -30M Q4 '22: -30.6M Q1 '23: -34.6M Q2 '23: -38.2M Q3 '23: -41.7M Q4 '23: -49M Q1 '24: -54.6M Q2 '24: -58.1M Q3 '24: -51M Q4 '24: -22.4M Q1 '25: 14.5M Q2 '25: 49.3M Q3 '25: 104M Q4 '25: 150.1M Q1 '26: 193.7M Q2 '26: 217M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income TTM

-70M 0 70M 140M 210M Q1 '11: -6.4M Q2 '11: -7.7M Q3 '11: -8.9M Q4 '11: -6.7M Q1 '12: -5.6M Q2 '12: -3.7M Q3 '12: -2.1M Q4 '12: -3.4M Q1 '13: -3.7M Q2 '13: -5.1M Q3 '13: -6.5M Q4 '13: -9.1M Q1 '14: -24.6M Q2 '14: -19.1M Q3 '14: -21.7M Q4 '14: -20.5M Q1 '15: -9.2M Q2 '15: -16.9M Q3 '15: -16.5M Q4 '15: -14.3M Q1 '16: -12.9M Q2 '16: -13.7M Q3 '16: -18.1M Q4 '16: -18.1M Q1 '17: -21.6M Q2 '17: -21.9M Q3 '17: -22.7M Q4 '17: -33M Q1 '18: -35.6M Q2 '18: -39M Q3 '18: -39.3M Q4 '18: -26.8M Q1 '19: -21.8M Q2 '19: -14M Q3 '19: -9M Q4 '19: -16.4M Q1 '20: -16.8M Q2 '20: -19.9M Q3 '20: -21.2M Q4 '20: -22M Q1 '21: -23.7M Q2 '21: -24.5M Q3 '21: -26.5M Q4 '21: -28.2M Q1 '22: -28M Q2 '22: -31M Q3 '22: -29.3M Q4 '22: -29.7M Q1 '23: -33.2M Q2 '23: -36.9M Q3 '23: -39.8M Q4 '23: -46.3M Q1 '24: -50.2M Q2 '24: -53.1M Q3 '24: -46.1M Q4 '24: -17.9M Q1 '25: 17.2M Q2 '25: 51.2M Q3 '25: 162.5M Q4 '25: 163.1M Q1 '26: 181M Q2 '26: 187.2M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Cost of Revenue TTM

-20M 0 20M 40M 60M Q4 '13: -201.6K Q1 '14: -282.6K Q2 '14: -337.1K Q3 '14: -373.8K Q4 '14: -445.8K Q1 '15: -382.1K Q2 '15: -429.4K Q3 '15: -428.1K Q4 '15: -154.7K Q1 '16: -87.1K Q2 '16: 201.9K Q3 '16: 281.2K Q4 '16: 281.3K Q1 '17: 324.6K Q2 '17: 155.5K Q3 '17: 178.2K Q4 '18: 396.8K Q1 '19: 595.2K Q2 '19: 582.6K Q3 '19: 349.2K Q4 '19: 373.2K Q1 '20: 194.8K Q2 '20: 192.9K Q3 '20: 193.7K Q4 '20: 204.8K Q1 '21: 217.7K Q2 '21: 212.9K Q3 '21: 158.2K Q4 '21: 148.9K Q1 '22: 89.1K Q2 '22: 75K Q3 '22: 51.3K Q4 '22: 3.7K Q4 '24: 3.1M Q1 '25: 3.8M Q2 '25: 5.2M Q3 '25: 12.1M Q4 '25: 22.1M Q1 '26: 32.6M Q2 '26: 45.2M Q4 '14 Q1 '16 Q2 '17 Q3 '19 Q4 '20 Q1 '22 Q1 '25 Q2 '26

Operating Cash Flow TTM

-90M 0 90M 180M 270M Q2 '11: -5.8M Q3 '11: -6.6M Q4 '11: -6.3M Q1 '12: -4.7M Q2 '12: -3.8M Q3 '12: -2.7M Q4 '12: -2.3M Q1 '13: -2.8M Q2 '13: -2.4M Q3 '13: -3.2M Q4 '13: -3.6M Q1 '14: -4.4M Q2 '14: -5.4M Q3 '14: -5.7M Q4 '14: -6.3M Q1 '15: -7.2M Q2 '15: -9.3M Q3 '15: -10.5M Q4 '15: -12.5M Q1 '16: -15.6M Q2 '16: -15.8M Q3 '16: -19.4M Q4 '16: -22.3M Q1 '17: -23.6M Q2 '17: -27.6M Q3 '17: -27.8M Q4 '17: -28.6M Q1 '18: -28.9M Q2 '18: -25.5M Q3 '18: -23.8M Q4 '18: -23.7M Q1 '19: -24M Q2 '19: -19.5M Q3 '19: -18.4M Q4 '19: -15.1M Q1 '20: -15.7M Q2 '20: -16.6M Q3 '20: -19.9M Q4 '20: -22M Q1 '21: -20.7M Q2 '21: -23M Q3 '21: -21.2M Q4 '21: -21.2M Q1 '22: -21.2M Q2 '22: -23.6M Q3 '22: -24.1M Q4 '22: -24.4M Q1 '23: -28M Q2 '23: -31.1M Q3 '23: -33.8M Q4 '23: -38.4M Q1 '24: -45.3M Q2 '24: -50.8M Q3 '24: -55.7M Q4 '24: -50.6M Q1 '25: -13.6M Q2 '25: 30.5M Q3 '25: 75M Q4 '25: 175M Q1 '26: 197.7M Q2 '26: 253.9M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow TTM

-90M 0 90M 180M 270M Q2 '12: -3.8M Q3 '12: -2.7M Q4 '12: -2.3M Q1 '13: -2.8M Q2 '13: -2.4M Q3 '13: -3.2M Q4 '13: -3.7M Q1 '14: -4.5M Q2 '14: -5.4M Q3 '14: -5.7M Q4 '14: -6.3M Q1 '15: -7.3M Q2 '15: -9.4M Q3 '15: -10.5M Q4 '15: -12.5M Q1 '16: -15.6M Q2 '16: -15.8M Q3 '16: -19.5M Q4 '16: -22.3M Q1 '17: -23.6M Q2 '17: -27.6M Q3 '17: -27.8M Q4 '17: -28.7M Q1 '18: -29.1M Q2 '18: -25.7M Q3 '18: -24M Q4 '18: -23.7M Q1 '19: -24M Q2 '19: -19.5M Q3 '19: -18.4M Q4 '19: -15.1M Q1 '20: -15.7M Q2 '20: -16.6M Q3 '20: -20M Q4 '20: -22.1M Q1 '21: -20.8M Q2 '21: -23.1M Q3 '21: -22.1M Q4 '21: -22.6M Q1 '22: -22.6M Q2 '22: -25M Q3 '22: -24.8M Q4 '22: -24.6M Q1 '23: -28.2M Q2 '23: -31.3M Q3 '23: -34M Q4 '23: -38.7M Q1 '24: -45.7M Q2 '24: -51.2M Q3 '24: -56.1M Q4 '24: -50.7M Q1 '25: -13.6M Q2 '25: 30.4M Q3 '25: 74.4M Q4 '25: 172.8M Q1 '26: 194.7M Q2 '26: 250.4M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q2 '13: 13M Q2 '14: 25.4M Q2 '15: 31.6M Q1 '21: 36.3M Q2 '21: 38.1M Q3 '21: 38.1M Q1 '22: 38.2M Q2 '22: 39.8M Q3 '22: 41.2M Q1 '23: 44.1M Q2 '23: 45.4M Q3 '23: 56.6M Q1 '24: 57.5M Q2 '24: 57.6M Q3 '24: 58.8M Q1 '25: 69M Q2 '25: 71.9M Q3 '25: 86.2M Q1 '26: 93M Q2 '26: 92.5M Q2 '14 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.40 -1.60 -0.80 0.00 0.80 1.60 2.40 Q1 '11: -0.48 Q2 '11: -0.60 Q3 '11: -0.71 Q4 '11: -0.58 Q1 '12: -0.49 Q2 '12: -0.32 Q3 '12: -0.18 Q4 '12: -0.30 Q1 '13: -0.35 Q2 '13: -0.45 Q3 '13: -0.54 Q4 '13: -0.69 Q1 '14: -1.43 Q2 '14: -1.33 Q3 '14: -1.38 Q4 '14: -1.24 Q1 '15: -0.60 Q2 '15: -0.68 Q3 '15: -0.59 Q4 '15: -0.61 Q1 '16: -0.49 Q2 '16: -0.49 Q3 '16: -0.58 Q4 '16: -0.63 Q1 '17: -0.71 Q2 '17: -0.68 Q3 '17: -0.62 Q4 '17: -0.62 Q1 '18: -1.11 Q2 '18: -1.53 Q3 '18: -1.90 Q4 '18: -1.51 Q1 '19: -1.05 Q2 '19: -0.56 Q3 '19: -1.37 Q4 '19: -1.78 Q1 '20: -1.77 Q2 '20: -1.88 Q3 '20: -0.75 Q4 '20: -0.76 Q1 '21: -0.75 Q2 '21: -0.73 Q3 '21: -0.73 Q4 '21: -0.75 Q1 '22: -0.73 Q2 '22: -0.80 Q3 '22: -0.75 Q4 '22: -0.74 Q1 '23: -0.80 Q2 '23: -0.86 Q3 '23: -0.86 Q4 '23: -0.92 Q1 '24: -0.93 Q2 '24: -0.93 Q3 '24: -0.81 Q4 '24: -0.30 Q1 '25: 0.25 Q2 '25: 0.78 Q3 '25: 2.09 Q4 '25: 1.91 Q1 '26: 2.04 Q2 '26: 2.05 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.